The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Neurobiological Interactions Between Stress and the Endocannabinoid System
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–280 of 280
Morozov, Y. M., Torii, M., & Rakic, P. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp028 · Cited by 94
Olango, W., Roche, M., Ford, G., Harhen, B., & Finn, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01478.x · Cited by 94
Tan, H., Lauzon, N. M., Bishop, S. F., Chi, N., Bechard, M., & Laviolette, S. R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4718-10.2011 · Cited by 92
Zhang, Z., Wang, W., Zhong, P., Liu, S. J., Long, J. Z., Zhao, L., Gao, H., Cravatt, B. F., & Liu, Q. (2015) · Hippocampus · doi:10.1002/hipo.22344 · Cited by 89
Atsak, P., Hauer, D., Campolongo, P., Schelling, G., Fornari, R. V., & Roozendaal, B. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.334 · Cited by 89
Depression and anxiety with rimonabant
Mitchell, P. B., & Morris, M. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61705-x · Cited by 89
Horder, J., Harmer, C. J., Cowen, P. J., & McCabe, C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000453 · Cited by 89
Arpana Agrawal, A., Nelson, E. C., Littlefield, A. K., Bucholz, K. K., Degenhardt, L. J., Henders, A. K., Madden, P. A. F., Martin, N. G., Montgomery, G. W., Pergadia, M. L., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2273 · Cited by 89
Sandi, C., Cordero, M. I., Ugolini, A., Varea, E., Caberlotto, L., & Large, C. H. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06451.x · Cited by 87
Kamprath, K., Romo-Parra, H., Häring, M., Gaburro, S., Doengi, M., Lutz, B., & Pape, H.-C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.196 · Cited by 86
Liposits, Z., & Bohn, M. C. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350103 · Cited by 86
Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward
Rademacher, D. J., & Hillard, C. J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.013 · Cited by 86
Roberto, M., Cruz, M. T., Bajo, M., Siggins, G. R., Parsons, L. H., & Schweitzer, P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.70 · Cited by 85
Navarria, A., Tamburella, A., Iannotti, F. A., Micale, V., Camillieri, G., Gozzo, L., Verde, R., Imperatore, R., Leggio, G. M., Drago, F., et al. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.014 · Cited by 85
Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83
Rossi, S., De Chiara, V., Musella, A., Sacchetti, L., Cantarella, C., Castelli, M., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064196 · Cited by 82
Ramikie, T. S., Nyilas, R., Bluett, R. J., Gamble‐George, J., Hartley, N. D., Mackie, K., Watanabe, M., Katona, I., & Patel, S. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.012 · Cited by 82
Self-citationChiara, V. D., Errico, F., Musella, A., Rossi, S., Mataluni, G., Sacchetti, L., Siracusano, A., Castelli, M., Cavasinni, F., Bernardi, G., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.141 · Cited by 82
Neumeister, A., Seidel, J., Ragen, B., & Pietrzak, R. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.012 · Cited by 79
Campos, A. C., Ferreira, F. R., Guimarães, F. S., & Lemos, J. I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.062 · Cited by 76
CB2: Therapeutic target-in-waiting
Atwood, B. K., Straiker, A. J., & Mackie, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.001 · Cited by 75
Bentz, D., Michael, T., Wilhelm, F., Hartmann, F., Kunz, S., von Rohr, I. R., & de Quervain, D. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.018 · Cited by 73
Huang, Y.-C., Wang, S., Chiou, L., & Gean, P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10311.2003 · Cited by 72
Optogenetic strategies to investigate neural circuitry engaged by stress
Sparta, D. R., Jennings, J. H., Ung, R. L., & Stuber, G. D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.05.007 · Cited by 72
Bowles, N. P., Hill, M. N., Bhagat, S. M., Karatsoreos, I. N., Hillard, C. J., & McEwen, B. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.048 · Cited by 70
Self-citationHorder, J., Cowen, P. J., Di Simplicio, M., Browning, M., & Harmer, C. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1517-4 · Cited by 69
Doyon, C., Denis, R., Baraboi, E., Samson, P., Lalonde, J., Deshaies, Y., & Richard, D. (2006) · Diabetes · doi:10.2337/db06-0504 · Cited by 69
Lee, T. T. Y., & Hill, M. N. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.017 · Cited by 68
Self-citationAzad, S. C., Kurz, J., Marsicano, G., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2008) · Learning & Memory · doi:10.1101/lm.741908 · Cited by 68
Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents
Wade, M. R., Degroot, A., & Nomikos, G. G. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.083 · Cited by 67
McLaughlin, R. J., Hill, M. N., Dang, S. S., Wainwright, S. R., Galea, L. A. M., Hillard, C. J., & Gorzalka, B. B. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.053 · Cited by 65
Self-citationStress response recruits the hippocampal endocannabinoid system for the modulation of fear memoryPreprint
Alvares, L. D. O., Engelke, D. S., Diehl, F., Scheffer-Teixeira, R., Haubrich, J., Cassini, L. F., Molina, V. A., & Quillfeldt, J. A. (2010) · Learning & Memory · doi:10.1101/lm.1721010 · Cited by 64
Ramikie, T. S., & Patel, S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.037 · Cited by 62
Fokos, S., & Panagis, G. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104904 · Cited by 61
Atkinson, H. C., Leggett, J. D., Wood, S. A., Castrique, E. S., Kershaw, Y. M., & Lightman, S. L. (2010) · Endocrinology · doi:10.1210/en.2010-0101 · Cited by 61
Gray, M. E., Bingham, B., & Viau, V. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01941.x · Cited by 60
Roberts, C. J., Stuhr, K. L., Hutz, M. J., Raff, H., & Hillard, C. J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.026 · Cited by 55
Newsom, R. J., Osterlund, C., Masini, C. V., Day, H. E., Spencer, R. L., & Campeau, S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.043 · Cited by 54
Tallett, A. J., Blundell, J. E., & Rodgers, R. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0880-2 · Cited by 53
Bedse, G., Colangeli, R., Lavecchia, A. M., Romano, A., Fabio Altieri, F., Cifani, C., Cassano, T., & Gaetani, S. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.005 · Cited by 52
Glangetas, C., Girard, D., Groc, L., Marsicano, G., Chaouloff, F., & Georges, F. E. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3175-13.2013 · Cited by 52
Campolongo, P., Ratano, P., Manduca, A., Scattoni, M. L., Palmery, M., Trezza, V., & Cuomo, V. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00011 · Cited by 52
Aliczki, M., Zelena, D., Mikics, E., Varga, Z. K., Pinter, O., Bakos, N. V., Varga, J., & Haller, J. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.03.017 · Cited by 50
Kim, S.-J., Park, S.-H., Choi, S.-H., Moon, B., Lee, K. J., Kang, S., Lee, M.-S., Choi, S.-H., Chun, B., & Shin, K.-H. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.003 · Cited by 50
Horder, J., Browning, M., Di Simplicio, M., Cowen, P. J., & Harmer, C. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111400649 · Cited by 48
Hu, W., Zhang, M., Czéh, B., Zhang, W., & Flügge, G. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.04.005 · Cited by 48
Radley, J. J. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00007 · Cited by 48
Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716
Singh, M. E., Verty, A. N. A., Price, I., McGregor, I. S., & Mallet, P. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.008 · Cited by 47
Mailleux, P., & Vanderhaeghen, J. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90437-p · Cited by 47
Reich, C. G., Mihalik, G. R., Iskander, A. N., Seckler, J. C., & Weiss, M. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.066 · Cited by 47
Wang, J., Shen, R., & Haj‐Dahmane, S. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238659 · Cited by 44
Mangieri, R. A., Hong, K., Piomelli, D., & Sinha, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1518-3 · Cited by 43
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats
Haller, J., Goldberg, S. R., Gyimesi-Pelczer, K., Aliczki, M., & Panlilio, L. V. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3161-2 · Cited by 41
Conzelmann, A., Reif, A., Jacob, C., Weyers, P., Lesch, K., Lutz, B., & Pauli, P. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2785-y · Cited by 41
Gamble‐George, J., Conger, J. R., Hartley, N. D., Gupta, P., Sumislawski, J. J., & Patel, S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3042-8 · Cited by 41
Self-citationHill, M. N., Ho, W.-S. V., Meier, S. E., Gorzalka, B. B., & Hillard, C. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.058 · Cited by 40
Self-citationInteractions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission
Mikics, É., Vas, J., Aliczki, M., Halász, J., & Haller, J. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c70b1 · Cited by 40
Haj‐Dahmane, S., & Shen, R. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1310-14.2014 · Cited by 40
Vaughn, L. K., Mantsch, J. R., Vranjkovic, O., Stroh, G., LaCourt, M., Kreutter, M., & Hillard, C. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.021 · Cited by 40
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing
Friemel, C. M., Zimmer, A., & Schneider, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.86 · Cited by 38
Aliczki, M., Balogh, Z., Tulogdi, A., & Haller, J. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283564dfa · Cited by 37
Marco, E. M., & Viveros, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789957468 · Cited by 36
Bergamaschi, M. M., Queiróz, R. H. C., Chagas, M. H. N., Linares, I. M. P., Arrais, K. C., de Oliveira, D. C. G., Queiroz, M. E. C., Nardi, A. E., Huestis, M. A., Hallak, J. E. C., et al. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2374 · Cited by 33
Kupferschmidt, D., Klas, P., & Erb, S. M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01983.x · Cited by 30
Opioid and cannabinoid receptors
Reisine, T., & Brownstein, M. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90103-1 · Cited by 29
Emotional, endocrine and brain anandamide response to social challenge in infant male rats
Marco, E. M., Scattoni, M. L., Rapino, C., Ceci, C., Chaves, N., Macrì, S., Maccarrone, M., & Laviola, G. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.04.004 · Cited by 28
Kurrikoff, K., Inno, J., Matsui, T., & Vasar, E. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06160.x · Cited by 27
Dominguez, G., Faucher, P., Henkous, N., Krazem, A., Pierard, C., & Béracochéa, D. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00166 · Cited by 25
Bouchez, G., Millan, M. J., Rivet, J., Billiras, R., Boulanger, R., & Gobert, A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.010 · Cited by 24
Ginsberg, A. B., Pecoraro, N. C., Warne, J. P., Horneman, H. F., & Dallman, M. F. (2010) · Stress · doi:10.3109/10253890903336839 · Cited by 24
Heinzmann, J.-M., Thoeringer, C. K., Knapman, A., Palme, R., Holsboer, F., Uhr, M., Landgraf, R., & Touma, C. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02062.x · Cited by 23
Corticosteroid–endocannabinoid loop supports decrease of fear-conditioned response in rats
de Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.010 · Cited by 23
Experience Salience Gates Endocannabinoid Signaling at Hypothalamic Synapses
Cusulin, J. I. W., Senst, L., Teskey, G. C., & Bains, J. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0163-14.2014 · Cited by 21
Self-citationSwim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol
Roberts, C. J., Stuhr, K. L., & Hillard, C. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.065 · Cited by 19
CB1 – Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men
Goodwin, R. S., Baumann, M. H., Gorelick, D. A., Schwilke, E. W., Schwope, D. M., Darwin, W. D., Kelly, D. L., Schroeder, J. R., Ortemann, C., BONNET, D., et al. (2011) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.600398 · Cited by 19
Neuromodulators, stress and plasticity: a role for endocannabinoid signalling
Senst, L., & Bains, J. S. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.089730 · Cited by 17
Self-citationWolkers, C. P. B., Barbosa, A., Menescal-de-Oliveira, L., & Hoffmann, A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.01.038 · Cited by 16
Melancholic features related to rimonabant
Viana, B. D. M., Prais, H. A. C., & Daker, M. V. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.009 · Cited by 15
Adrenocortical function, feedback, and alphabet soup
Dallman, M. F. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/classicessays.00033.2005 · Cited by 10
The Bed Nucleus of the Stria Terminalis
Marino, V. D., Etienne, Y., & Niddam, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-23243-0_10 · Cited by 8
Cited by
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa018 · Cited by 260
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 267
The endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233
Self-citation
Metadata
- Authors
- Morena, M., Patel, S., Bains, J. S., & Hill, M. N.
- Venue
- Neuropsychopharmacology
- Published
- 2015-06-12
- Volume
- 41
- Issue
- 1
- Pages
- 80-102
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2257383498
- Cited by
- 660
- References
- 280
- FWCI
- 27.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.